Jane Street’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Sell |
42,764
-98,120
| -70% | -$1.08M | ﹤0.01% | 3777 |
|
|
2025
Q1 | $1.26M | Buy |
140,884
+88,540
| +169% | +$791K | ﹤0.01% | 2774 |
|
|
2024
Q4 | $493K | Sell |
52,344
-92,231
| -64% | -$868K | ﹤0.01% | 3979 |
|
|
2024
Q3 | $1.17M | Buy |
144,575
+1,640
| +1% | +$13.2K | ﹤0.01% | 3179 |
|
|
2024
Q2 | $1.21M | Buy |
142,935
+109,327
| +325% | +$927K | ﹤0.01% | 3411 |
|
|
2024
Q1 | $301K | Sell |
33,608
-337,909
| -91% | -$3.03M | ﹤0.01% | 4627 |
|
|
2023
Q4 | $4.18M | Sell |
371,517
-87,994
| -19% | -$989K | ﹤0.01% | 1683 |
|
|
2023
Q3 | $3.97M | Buy |
459,511
+33,091
| +8% | +$286K | ﹤0.01% | 1522 |
|
|
2023
Q2 | $4.41M | Buy |
426,420
+303,654
| +247% | +$3.14M | ﹤0.01% | 1619 |
|
|
2023
Q1 | $1.33M | Sell |
122,766
-23,388
| -16% | -$254K | ﹤0.01% | 2483 |
|
|
2022
Q4 | $1.64M | Sell |
146,154
-43,793
| -23% | -$491K | ﹤0.01% | 2160 |
|
|
2022
Q3 | $1.93M | Buy |
189,947
+103,214
| +119% | +$1.05M | ﹤0.01% | 2123 |
|
|
2022
Q2 | $786K | Sell |
86,733
-36,601
| -30% | -$332K | ﹤0.01% | 3051 |
|
|
2022
Q1 | $1.18M | Buy |
123,334
+70,068
| +132% | +$670K | ﹤0.01% | 2748 |
|
|
2021
Q4 | $589K | Buy |
53,266
+38,820
| +269% | +$429K | ﹤0.01% | 3287 |
|
|
2021
Q3 | $107K | Buy |
+14,446
| New | +$107K | ﹤0.01% | 4672 |
|
|
2021
Q2 | – | Sell |
-14,192
| Closed | -$290K | – | 5744 |
|
|
2021
Q1 | $290K | Buy |
+14,192
| New | +$290K | ﹤0.01% | 3946 |
|
|
2020
Q4 | – | Sell |
-21,140
| Closed | -$313K | – | 4406 |
|
|
2020
Q3 | $313K | Sell |
21,140
-1,197,772
| -98% | -$17.7M | ﹤0.01% | 2827 |
|
|
2020
Q2 | $25.6M | Buy |
+1,218,912
| New | +$25.6M | 0.02% | 180 |
|
|
2018
Q2 | – | Sell |
-141,329
| Closed | -$3.43M | – | 3720 |
|
|
2018
Q1 | $3.43M | Buy |
+141,329
| New | +$3.43M | 0.01% | 635 |
|
|
2016
Q2 | – | Sell |
-10,584
| Closed | -$199K | – | 2948 |
|
|
2016
Q1 | $199K | Buy |
+10,584
| New | +$199K | ﹤0.01% | 2299 |
|